standard breakfast

OTHER3 trials

Sponsors

Boehringer Ingelheim, TNO

Conditions

HealthyObesity

Phase 1

Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers

CompletedNCT02265640

Boehringer IngelheimHealthy

Start: 2000-10-31Updated: 2014-10-16

Relative Bioavailability, Safety and Tolerability of Two Tablet Formulations of BIIL 284 BS

CompletedNCT02265666

Boehringer IngelheimHealthy

Start: 2001-10-31Updated: 2014-10-16

Phase 2

Breakfast Test Products and Acute Satiety Scores

CompletedNCT02575131

Start: 2015-10-31End: 2016-07-31Updated: 2016-10-19